Evolent Health Stock Performance
| EVH Stock | USD 9.35 0.86 8.42% |
Evolent Health has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 2.56, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Evolent Health will likely underperform. Evolent Health right now shows a risk of 4.99%. Please confirm Evolent Health sortino ratio, skewness, period momentum indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Evolent Health will be following its price patterns.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Evolent Health are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Evolent Health may actually be approaching a critical reversion point that can send shares even higher in August 2025. ...more
Actual Historical Performance (%)
One Day Return (8.42) | Five Day Return (16.52) | Year To Date Return (18.62) | Ten Year Return (54.08) | All Time Return (50.42) |
1 | Evolent Health Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations | 05/08/2025 |
2 | Evolent Health stock hits 52-week low at 8.35 By Investing.com - Investing.com India | 05/21/2025 |
3 | Acquisition by Ajayi Toyin of 7709 shares of Evolent Health subject to Rule 16b-3 | 06/06/2025 |
4 | Evolent Health backs Q2 adjusted EBITDA view 33M-40M EVH | 06/20/2025 |
5 | JMP Maintains Price Target and Market Outperform Rating on Evolent Health | 07/03/2025 |
6 | Evolent Health appoints Lim as chief clinical officer, Way as CFO EVH | 07/09/2025 |
7 | Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025 EVH ... | 07/14/2025 |
8 | Truist Securities Raises Price Target for Evolent Health EVH Stock News | 07/17/2025 |
9 | Elevance Health, EchoStar, Icahn Enterprises, Evolent Health, and The Trade Desk Shares Are Soaring, What You Need To Know | 07/23/2025 |
| Begin Period Cash Flow | 223.5 M | |
| Total Cashflows From Investing Activities | -62.9 M |
Evolent Health Relative Risk vs. Return Landscape
If you would invest 934.00 in Evolent Health on April 26, 2025 and sell it today you would earn a total of 1.00 from holding Evolent Health or generate 0.11% return on investment over 90 days. Evolent Health is generating 0.1273% of daily returns assuming volatility of 4.9929% on return distribution over 90 days investment horizon. In other words, 44% of stocks are less volatile than Evolent, and above 98% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Evolent Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Evolent Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Evolent Health, and traders can use it to determine the average amount a Evolent Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0255
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | EVH | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.99 actual daily | 44 56% of assets are more volatile |
Expected Return
| 0.13 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Evolent Health is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Evolent Health by adding it to a well-diversified portfolio.
Evolent Health Fundamentals Growth
Evolent Stock prices reflect investors' perceptions of the future prospects and financial health of Evolent Health, and Evolent Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Evolent Stock performance.
| Return On Equity | -0.0924 | ||||
| Return On Asset | -4.0E-4 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 1.82 B | ||||
| Shares Outstanding | 117.4 M | ||||
| Price To Earning | (13.88) X | ||||
| Price To Book | 1.28 X | ||||
| Price To Sales | 0.50 X | ||||
| Revenue | 2.55 B | ||||
| Gross Profit | 365.72 M | ||||
| EBITDA | 84.85 M | ||||
| Net Income | (61.62 M) | ||||
| Cash And Equivalents | 104.2 M | ||||
| Cash Per Share | 1.57 X | ||||
| Total Debt | 713.67 M | ||||
| Debt To Equity | 0.56 % | ||||
| Current Ratio | 1.03 X | ||||
| Book Value Per Share | 8.07 X | ||||
| Cash Flow From Operations | 18.77 M | ||||
| Earnings Per Share | (1.23) X | ||||
| Market Capitalization | 1.2 B | ||||
| Total Asset | 2.54 B | ||||
| Retained Earnings | (780.82 M) | ||||
| Working Capital | (108.38 M) | ||||
| Current Asset | 184.46 M | ||||
| Current Liabilities | 59.51 M | ||||
About Evolent Health Performance
By evaluating Evolent Health's fundamental ratios, stakeholders can gain valuable insights into Evolent Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Evolent Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Evolent Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (168.61) | (177.04) | |
| Return On Tangible Assets | (0.08) | (0.09) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.02) | (0.03) | |
| Return On Equity | (0.06) | (0.06) |
Things to note about Evolent Health performance evaluation
Checking the ongoing alerts about Evolent Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Evolent Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Evolent Health had very high historical volatility over the last 90 days | |
| The company reported the last year's revenue of 2.55 B. Reported Net Loss for the year was (61.62 M) with profit before taxes, overhead, and interest of 365.72 M. | |
| Over 98.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Elevance Health, EchoStar, Icahn Enterprises, Evolent Health, and The Trade Desk Shares Are Soaring, What You Need To Know |
- Analyzing Evolent Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Evolent Health's stock is overvalued or undervalued compared to its peers.
- Examining Evolent Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Evolent Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Evolent Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Evolent Health's stock. These opinions can provide insight into Evolent Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |